pulmonary arterial hypertension

Bishop chess chess bishop diagonal chessboard

Series B round of $125M will fund Diagonal's move into clinic

With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug, DIAG723.

Kevin Dunleavy Jan 8, 2026 6:30am

Keros shakes up leadership structure to go all in on DMD drug

Aug 7, 2025 6:15am

Keros culls phase 2 PAH program, 70 staff roles

May 29, 2025 10:10am

visual of neurons under Parkinsons disease

Inhibikase hits pause on Parkinson's program over efficacy

Jan 30, 2025 4:30am

Keros halts 2 arms of hypertension trial over fluid near heart

Dec 12, 2024 6:30am

A doctor with a graphic representation of the lungs

Cereno's HDAC inhibitor reduces risks from PAH in phase 2 trial

Sep 30, 2024 9:35am